Gilles Collin

Université Claude Bernard Lyon 1 — France

Immunology and Microbiology · Life Sciences

31h-index2.5kcitations87works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(56), HIV/AIDS drug development and treatment(50), HIV/AIDS Research and Interventions(25), SARS-CoV-2 and COVID-19 Research(12), SARS-CoV-2 detection and testing(7)

Publications87 total

Higher levels of host-cell DNA methylation markers ZNF582 and ASCL1 on anal smears are predictive for progression to anal cancer in patients with previous high-grade lesions
EBioMedicine·2025· 1 citedOpen Access
Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial
The Lancet HIV·2024· 7 citedOpen Access
Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021
Virus Research·2022· 12 citedOpen Access
Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration
Journal of Virology·2022· 24 citedOpen Access
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
Journal of Infection·2022· 8 citedOpen Access
Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
Frontiers in Cellular and Infection Microbiology·2021· 1 citedOpen Access
Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
Journal of Infection·2021· 5 citedOpen Access
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
Journal of Thoracic Oncology·2021· 62 citedOpen Access
<i>In vitro</i> analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions
Journal of Antimicrobial Chemotherapy·2021· 3 cited
Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient
Vaccines·2021· 3 citedOpen Access
Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine
Journal of Infection·2021· 7 citedOpen Access
Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses
2021· 8 citedOpen Access
Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis
Vaccines·2021· 7 citedOpen Access
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings
Journal of Clinical Virology·2021· 14 citedOpen Access
Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
Journal of Virological Methods·2021· 31 citedOpen Access
New insights in COVID-19–associated chilblains: A comparative study with chilblain lupus erythematosus
Journal of the American Academy of Dermatology·2020· 44 citedOpen Access
No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis
ERJ Open Research·2020· 3 citedOpen Access
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
Journal of Clinical Virology·2020· 50 citedOpen Access
Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
Journal of Clinical Microbiology·2020· 113 citedOpen Access
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial)
Journal of Antimicrobial Chemotherapy·2020· 13 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Florence Damond(26), Françoise Brun‐Vézinet(26), Diane Descamps(25), Diane Descamps(19), Sophie Matheron(19), Benoît Visseaux(12), Geneviève Chêne(10), Charlotte Charpentier(10), Quentin Le Hingrat(9), Charlotte Charpentier(9), Bénédicte Roquebert(8), Cristian Apetrei(7), Valentine Marie Ferré(7), Alexandre Storto(7), Antoine Bénard(6), Lucile Larrouy(6), Gilles Peytavin(6), François Simon(5), Gilles Peytavin(5), Pauline Campa(5)